Published in Clin Exp Immunol on August 01, 1990
Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect Immun (1993) 1.59
Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response. J Infect Dis (2007) 1.22
T-Cell responses during Trypanosoma brucei infections in mice deficient in inducible nitric oxide synthase. Infect Immun (1999) 1.07
In vitro simulation of immunosuppression caused by Trypanosoma brucei: active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression. Infect Immun (1996) 1.03
Inhibition of T-cell responsiveness during experimental infections with Trypanosoma brucei: active involvement of endogenous gamma interferon. Infect Immun (1993) 1.01
The gene for a T lymphocyte triggering factor from African trypanosomes. J Exp Med (1997) 0.99
Elimination of IgE regulatory rat CD8+ T cells in vivo differentially modulates interleukin-4 and interferon-gamma but not interleukin-2 production by splenic T cells. Immunology (1993) 0.94
Effects of CD8 depletion on retinal soluble antigen induced experimental autoimmune uveoretinitis. Immunology (1993) 0.91
IgE antibody production is associated with suppressed interferon-gamma levels in mesenteric lymph nodes of rats infected with the nematode Nippostrongylus brasiliensis. Immunology (1994) 0.85
A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle. Immunology (1991) 0.83
Suppression by Trypanosoma brucei rhodesiense of the capacities of human T lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation. Infect Immun (1991) 0.81
Modulation of immune responses and suppression of experimental autoimmune myasthenia gravis by surgical denervation of the spleen. Clin Exp Immunol (2006) 0.77
TLTF in cerebrospinal fluid for detection and staging of T. b. gambiense infection. PLoS One (2013) 0.75
Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med (1983) 14.08
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med (1989) 11.36
Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur J Immunol (1980) 5.98
Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. J Clin Invest (1983) 5.88
Inducible expression of H-2 and Ia antigens on brain cells. Nature (1984) 3.48
Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods (1988) 2.84
Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science (1987) 2.69
Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med (1985) 2.34
The purification and characterization of rat gamma interferon by use of two monoclonal antibodies. J Gen Virol (1986) 2.29
Letter: Substitute for benzidine in myeloperoxidase stains. Am J Clin Pathol (1975) 2.07
The nature of immunosuppression in Trypanosoma brucei infections in mice. I. The role of the macrophage. Immunology (1974) 1.81
In vivo treatment of rats with monoclonal anti-T-cell antibodies. Immunohistochemical and functional analysis in normal rats and in experimental allergic neuritis. Scand J Immunol (1985) 1.20
Spread of Trypanosoma brucei to the nervous system: early attack on circumventricular organs and sensory ganglia. J Neurosci Res (1988) 1.15
Production of interferons during experimental African trypanosomiasis. Clin Exp Immunol (1983) 1.07
Inhibition of macrophage-induced antigen-specific T-cell proliferation by interferon-gamma. Cell Immunol (1988) 1.02
Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. II. Cytotoxic T lymphocytes. Scand J Immunol (1986) 0.96
Interaction of African trypanosomes with the immune system. Philos Trans R Soc Lond B Biol Sci (1984) 0.87
Early major histocompatibility complex (MHC) class I antigen induction in hypothalamic supraoptic and paraventricular nuclei in trypanosome-infected rats. J Neuroimmunol (1989) 0.83
Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. Cell (1997) 3.72
Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science (1986) 3.33
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol (2000) 2.99
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol (1998) 2.97
Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J Intern Med (2013) 2.74
Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab (2001) 2.33
Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology (2011) 2.26
Neuritic transport of herpes simplex virus in rat sensory neurons in vitro. Effects of substances interacting with microtubular function and axonal flow [nocodazole, taxol and erythro-9-3-(2-hydroxynonyl)adenine]. J Gen Virol (1986) 2.24
Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia (2007) 2.23
Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture. J Gen Virol (1984) 2.22
Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab (2011) 2.16
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology (2011) 2.07
HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol (2000) 2.05
Cancer risk among patients with multiple sclerosis and their parents. Neurology (2009) 2.03
Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids (1991) 1.90
Spread of herpes simplex virus in peripheral nerves. Acta Neuropathol (1971) 1.87
The perineurium as a diffusion barrier to protein tracers. Differences between mature and immature animals. Acta Neuropathol (1971) 1.67
Neural spread of herpes simplex virus types 1 and 2 in mice after corneal or subcutaneous (footpad) inoculation. J Neurol Sci (1978) 1.66
Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis. Mult Scler (2012) 1.65
T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol (1991) 1.65
Hemiosteoporosis after severe stroke, independent of changes in body composition and weight. Stroke (1999) 1.63
Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo. J Gen Virol (1985) 1.62
Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke (1997) 1.61
Retrograde axonal transport of protein. Brain Res (1971) 1.61
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet (2008) 1.59
Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect Immun (1993) 1.59
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology (2009) 1.59
Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biol Psychiatry (1996) 1.56
Leptin is associated with increased risk of myocardial infarction. J Intern Med (1999) 1.52
Fractures after stroke. Osteoporos Int (1998) 1.47
Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci (2000) 1.44
Detection of intracellular expression and secretion of interferon-gamma at the single-cell level after activation of human T cells with tetanus toxoid in vitro. Eur J Immunol (1990) 1.42
Axonal uptake and retrograde transport of exogenous proteins in the hypoglossal nerve. Brain Res (1971) 1.42
Maternal smoking during pregnancy and multiple sclerosis amongst offspring. Eur J Neurol (2008) 1.41
[Cervical manipulation--is it really justifiable?]. Lakartidningen (1992) 1.39
Bronchostenosis due to sarcoidosis: a cause of atelectasis and airway obstruction simulating pulmonary neoplasm and chronic obstructive pulmonary disease. Chest (1979) 1.39
Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care (2001) 1.38
Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci U S A (1996) 1.38
A population-based study of coeliac disease, neurodegenerative and neuroinflammatory diseases. Aliment Pharmacol Ther (2007) 1.37
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36
Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement. J Neuroimmunol (2000) 1.36
Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol (1991) 1.36
A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) (1996) 1.36
Persistence of RNA viruses in the central nervous system. Annu Rev Microbiol (1986) 1.33
Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis. Ann Neurol (1994) 1.33
MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest (1998) 1.33
Morphological studies of the neural spread of herpes simplex virus to the central nervous system. Acta Neuropathol (1970) 1.32
Changes in the vagus nerve in diabetes mellitus. Acta Pathol Microbiol Scand A (1971) 1.32
Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol (1994) 1.31
Study on the propagation of Herpes simplex virus (type 2) into the brain after intraocular injection. Brain Res (1974) 1.31
Leptin, but not adiponectin, predicts stroke in males. J Intern Med (2004) 1.31
Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. J Intern Med (2000) 1.29
Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun (2005) 1.28
Regulation of telomere length by checkpoint genes in Schizosaccharomyces pombe. Mol Biol Cell (1998) 1.27
CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Cell (1993) 1.27
Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch Toxicol (1987) 1.26
Retrograde transport of horseradish peroxidase in transected axons. 3. Entry into injured axons and subsequent localization in perikaryon. Brain Res (1976) 1.22
In vivo treatment of rats with monoclonal anti-T-cell antibodies. Immunohistochemical and functional analysis in normal rats and in experimental allergic neuritis. Scand J Immunol (1985) 1.20
The effect of cytochalasin D and monensin on enveloped vaccinia virus release. Arch Virol (1982) 1.20
Leptin is associated with increased prostate cancer risk: a nested case-referent study. J Clin Endocrinol Metab (2001) 1.20
Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant. J Neuroimmunol (1995) 1.19
Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model. Neuropathol Appl Neurobiol (2001) 1.18
Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun (2011) 1.17
Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. J Neuroimmunol (1995) 1.17
Expression of MHC class I and beta2-microglobulin in rat spinal motoneurons: regulatory influences by IFN-gamma and axotomy. Exp Neurol (1998) 1.17
Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis (2001) 1.16
Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid. J Neurol Sci (1998) 1.16
Spread of Trypanosoma brucei to the nervous system: early attack on circumventricular organs and sensory ganglia. J Neurosci Res (1988) 1.15
Measles virus matrix protein detected by immune fluorescence with monoclonal antibodies in the brain of patients with subacute sclerosing panencephalitis. J Virol (1985) 1.15
Transport of fluorescent protein tracer in peripheral nerves. Acta Neuropathol (1970) 1.15
Specific interactions between retrovirus Env and Gag proteins in rat neurons. J Virol (1998) 1.15
Selective infections of olfactory and respiratory epithelium by vesicular stomatitis and Sendai viruses. Neuropathol Appl Neurobiol (1987) 1.14
The perineurium as a diffusion barrier to protein tracers following trauma to nerves. Acta Neuropathol (1973) 1.14
Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand J Immunol (2002) 1.14
Bidirectional activating signals between Trypanosoma brucei and CD8+ T cells: a trypanosome-released factor triggers interferon-gamma production that stimulates parasite growth. Eur J Immunol (1991) 1.14
Expression of MHC class I heavy chain and beta2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons. J Neuroimmunol (1999) 1.14
Environmental influences on psychological restoration. Scand J Psychol (1996) 1.13
Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res (1995) 1.13
Neuron to neuron transmission of herpes simplex virus. Transport of virus from skin to brainstem nuclei. J Neurol Sci (1982) 1.12
Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification. Clin Chem (1984) 1.12
Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J Clin Invest (1991) 1.10
Chronic relapsing experimental allergic encephalomyelitis. Studies in vascular permeability changes. Acta Neuropathol (1977) 1.10
Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J Neurochem (1992) 1.09
Frequency of edentulism and identification marking of removable dentures in long-term care units. J Oral Rehabil (1996) 1.09
Some pharmacological properties of terbutaline (INN), 1-(3,5-dihydroxyphenyl)-2-(T-butylamino)-ethanol. A new sympathomimetic beta-receptor-stimulating agent. Acta Med Scand Suppl (1970) 1.08
Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol (1993) 1.07
Detection of C polysaccharide in Streptococcus pneumoniae in the sputa of pneumonia patients by an enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 1.07
Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15. Eur J Neurol (2012) 1.07
Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance. Metabolism (2004) 1.07
Myelin antigen reactive T cells in cerebrovascular diseases. Clin Exp Immunol (1992) 1.07
Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression. Mult Scler (2008) 1.06
Lipid compositions of different regions of the human brain during aging. J Neurochem (1990) 1.06
Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats. Neuroscience (1995) 1.06
Measles virus in the brain. Brain Res Bull (1997) 1.05
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers. Eur J Neurol (2009) 1.05
Increased mRNA expression of IL-6, IL-10, TNF-alpha, and perforin in blood mononuclear cells in human HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.05